tiprankstipranks
Trending News
More News >
Menora Mivtachim Holdings Ltd. (IL:MMHD)
:MMHD
Israel Market

Menora Miv Hld (MMHD) AI Stock Analysis

Compare
2 Followers

Top Page

IL:MMHD

Menora Miv Hld

(MMHD)

Select Model
Select Model
Select Model
Outperform 71 (OpenAI - 5.2)
Rating:71Outperform
Price Target:
48,620.00
▲(24.67% Upside)
The score is driven primarily by improved TTM profitability and strong free cash flow, tempered by revenue decline, rising leverage, and historically inconsistent cash flows. Valuation is supportive (P/E ~12.1 and ~2.94% yield), while technicals are mixed with weaker near-term momentum despite a positive MACD.
Positive Factors
Improved profitability and margins
A meaningful TTM jump in net income and net margin provides a larger earnings buffer against underwriting cycles and investment volatility. Elevated margins improve retained earnings and internal capital for reinvestment, supporting sustainable dividend and reserve funding if maintained.
Strong free cash flow generation
Robust trailing‑twelve‑month operating and free cash flow strengthens the firm's ability to fund claims, pay dividends, service debt, and pursue investments without relying on external financing. Durable cash generation underpins capital allocation flexibility over coming quarters.
Diversified insurance and investment model
A business mix across life, health, general insurance and direct investments provides multiple revenue streams and risk diversification. This structural diversification supports resilience to segment-specific shocks and offers cross‑sell and asset‑liability management benefits over the medium term.
Negative Factors
Top-line decline
A nearly 10% TTM revenue decline signals potential demand, pricing, or new‑business headwinds that can erode scale and long‑run growth. Even with margin gains, sustained top‑line weakness would pressure premium growth, constrain cross‑sell opportunities and limit long‑term earnings expansion.
Rising leverage
Material increase in debt‑to‑equity over recent years reduces financial flexibility and raises refinancing and interest‑rate sensitivity. Higher leverage could limit strategic investments or dividend policy and increase vulnerability if underwriting margins or investment returns revert to lower levels.
Historical cash‑flow volatility
Past episodes of negative operating and free cash flow indicate cyclicality and working‑capital timing risks. This volatility undermines predictability of funds for claims, capital needs, and buybacks, complicating planning and raising the chance of external funding needs during stress periods.

Menora Miv Hld (MMHD) vs. iShares MSCI Israel ETF (EIS)

Menora Miv Hld Business Overview & Revenue Model

Company DescriptionMenora Mivtachim Holdings Ltd operates in insurance and finance sectors in Israel. The company offers life and health, and general insurance products, as well as automobile insurance products, such as compulsory automobile or property car insurance products; and pension and provident funds. It also engages in the mutual funds and portfolio management, securities underwriting, and real estate investment activities. The company was formerly known as General Liability Office Ltd. and changed its name to Menora Mivtachim Holdings Ltd in 2006. Menora Mivtachim Holdings Ltd was founded in 1935 and is based in Tel Aviv, Israel.
How the Company Makes MoneyMenora Miv Hld generates revenue primarily through its insurance operations, where it earns premiums from policyholders in various sectors such as life, health, and general insurance. The company also makes money from investment income generated from its diverse portfolio, including equities, bonds, and real estate investments. Additionally, MMHD may benefit from fees and commissions related to its financial services. Strategic partnerships with other financial institutions and companies in the insurance space further enhance its revenue streams, while efficient risk management and underwriting practices contribute to maintaining profitability.

Menora Miv Hld Financial Statement Overview

Summary
Financial results improved notably in TTM with higher net income (2.04B vs 1.08B in 2024), stronger net margin (~17.7% vs ~7.3%), and strong free cash flow (2.18B, up ~27.7%). Offsetting this, revenue declined ~9.4%, leverage has risen (debt-to-equity ~0.76 vs ~0.60 in 2024), and historical cash-flow volatility (including negative OCF/FCF in 2022–2023) reduces visibility.
Income Statement
78
Positive
Profitability has strengthened meaningfully into TTM (Trailing-Twelve-Months): net income rose to 2.04B vs 1.08B in 2024, with a higher net margin (~17.7% vs ~7.3%) and stronger operating profitability. That said, the top line softened in TTM with revenue down ~9.4%, and results have been volatile across prior years (including very large revenue swings), which reduces visibility despite the current margin step-up.
Balance Sheet
70
Positive
The company shows solid profitability on shareholder capital (return on equity ~27.2% in TTM, up from ~15.0% in 2024), supporting balance-sheet quality. Leverage is moderate but trending higher: debt-to-equity increased to ~0.76 in TTM from ~0.60 in 2024 (and ~0.33 in 2021), suggesting a higher reliance on debt that could limit flexibility if earnings normalizes.
Cash Flow
73
Positive
Cash generation is strong in the most recent period, with operating cash flow of 2.45B and free cash flow of 2.18B in TTM (Trailing-Twelve-Months), and free cash flow growth up ~27.7%. Free cash flow broadly tracks earnings (about ~0.89x net income in TTM), but cash flows have been inconsistent historically, including negative operating and free cash flow in 2022–2023, which raises cyclicality/working-capital timing risk.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue11.49B14.78B12.57B5.89B12.99B9.53B
Gross Profit11.49B13.92B11.77B5.20B12.29B8.76B
EBITDA3.58B2.17B1.28B1.15B1.30B1.23B
Net Income2.04B1.08B516.08M536.04M655.68M647.69M
Balance Sheet
Total Assets78.66B74.18B70.03B67.58B66.79B61.92B
Cash, Cash Equivalents and Short-Term Investments4.84B3.98B3.40B11.79B12.59B11.23B
Total Debt6.47B4.34B3.72B3.43B1.82B2.16B
Total Liabilities69.86B66.76B63.42B61.51B61.18B57.06B
Stockholders Equity8.53B7.21B6.43B5.90B5.54B4.85B
Cash Flow
Free Cash Flow2.18B1.36B-578.42M-872.23M994.26M1.65B
Operating Cash Flow2.45B1.66B-324.60M-637.71M1.24B1.86B
Investing Cash Flow-738.20M-541.09M-269.12M-253.47M-240.94M-440.12M
Financing Cash Flow212.78M-547.84M104.00M189.97M-541.82M30.23M

Menora Miv Hld Technical Analysis

Technical Analysis Sentiment
Positive
Last Price39000.00
Price Trends
50DMA
40179.80
Positive
100DMA
36600.57
Positive
200DMA
30354.36
Positive
Market Momentum
MACD
562.39
Negative
RSI
66.34
Neutral
STOCH
95.30
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:MMHD, the sentiment is Positive. The current price of 39000 is below the 20-day moving average (MA) of 40009.00, below the 50-day MA of 40179.80, and above the 200-day MA of 30354.36, indicating a bullish trend. The MACD of 562.39 indicates Negative momentum. The RSI at 66.34 is Neutral, neither overbought nor oversold. The STOCH value of 95.30 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IL:MMHD.

Menora Miv Hld Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
₪41.55B13.614.19%12.22%71.58%
76
Outperform
₪32.43B13.5223.23%2.21%5.84%138.80%
71
Outperform
₪27.45B13.372.61%23.28%124.99%
70
Outperform
₪18.73B13.440.30%6.00%36.33%
69
Neutral
₪19.16B10.171.67%-27.87%229.49%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
60
Neutral
₪3.66B10.635.98%19.48%53.61%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IL:MMHD
Menora Miv Hld
44,400.00
27,845.94
168.21%
IL:CLIS
Clal Insurance
24,090.00
14,304.80
146.19%
IL:HARL
Harel
15,850.00
9,851.93
164.25%
IL:MGDL
Migdal Insur.
1,800.00
1,025.10
132.29%
IL:PHOE
Phoenix
16,390.00
10,327.50
170.35%
IL:IDIN
Idi Insur
24,690.00
10,041.71
68.55%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 13, 2026